Y. Lien

Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis.

M. Chonchol, J. Coburn, C. Charytan, 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Enzyme-Replacement Therapy With Agalsidase Alfa in Children With Fabry Disease

R. Schiffmann, B. Schlaggar, R. Brady, 2006, Pediatrics.

Tolvaptan and its potential in the treatment of hyponatremia

Y. Lien, ME Dixon, 2008, Therapeutics and clinical risk management.

Safety and efficacy of enzyme replacement therapy with agalsidase beta: an international, open-label study in pediatric patients with Fabry disease.

J. E. Wraith, A. Tylki-Szymańska, A. Vellodi, 2008, The Journal of pediatrics.

Four-year prospective clinical trial of agalsidase alfa in children with Fabry disease.

R. Schiffmann, T. Reimschisel, G. Pastores, 2010, The Journal of pediatrics.

Unexpected Severe LVH in the Elderly: Consider Fabry's Disease

William D. Ross, V. Sorrell, Y. Lien, 2008, Echocardiography.

Remission of posttransplant lymphoproliferative disorder after interferon alfa therapy.

J. Logan, S. O'Brien, R. Bernert, 1997, Journal of the American Society of Nephrology : JASN.

Extended epoetin alfa dosing as maintenance treatment for the anemia of chronic kidney disease: the PROMPT study.

Ashutosh Kumar Singh, C. Ghossein, David Steven Scott, 2005, Clinical nephrology.